Page results
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
This page has been written for patients who are having radiotherapy to the breast or chest wall area.
-
CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. University College London Hospitals (UCLH) is proud to be one of Europe’s leading centres for this advanced care.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
This page is intended for patients who suffer from laryngeal dystonia (formerly known as spasmodic dysphonia) who might benefit from this therapy.
-
This page is designed for patients scheduled to attend the Adult diagnostic audiology department. It outlines the various tests that may be conducted during your appointment.
-
For people with autoimmune conditions, including multiple sclerosis (MS) and scleroderma: Collecting stem cells from your blood
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
File results
-
FOI/2023/0250 - Early Access to Medicines Scheme (EAMS)
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0270 - Total agency spend and midwifery spend from 2018/19 to 2022/23
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0231 - Patients seen at A&E with symptoms of taking nitrous oxide gas
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023
-
FOI/2023/0202 - Nitrous oxide/ Entonox personal sampling for staff
-
FOI/2023/0203 - Maintenance contract(s) for flexible endoscope inventory
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0188 - Payments to suppliers